Print This Page

November 4, 2015

United States

New Jersey—Zoetis Gets Pharmaq’s “Romet 30®


London private equity firm Permira has agreed to sell Norwegian aquatic health specialist Pharmaq to pet and livestock pharmaceutical company Zoetis for $765 million.  Zoetis, a global animal health company, will acquire Pharmaq’s “Romet 30®”, which has been effective in the treatment of early mortality syndrome (EMS) in shrimp.


Information: Juan Ramón, CEO, Zoetis, 100 Campus Drive, Florham Park, New Jersey 07932, United States (phone  +1-973-822-7000, email, webpage


Sources: 1. The Street.  Zoetis Hooks Norway’s Pharmaq in $765 Million Deal.  Michael Brown and Renee Cordes.  November 3, 2015.  2. Pharmaq’s Webpage.  Webpage Visit on November 4, 2015.

Print This Page